Anti‐COVID‐19 measurements for hidradenitis suppurativa patients

The reported incidence of COVID‐19 among cohorts of patients with inflammatory bowel and skin diseases under treatment with biologicals is low. Treatment may further modify disease severity as some biological modifiers, such as anakinra, are also proposed for the management of COVID‐19 patients pote...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Exp Dermatol
Hoofdauteurs: Giamarellos‐Bourboulis, Evangelos J., Bettoli, Vincenzo, Jemec, Gregor B. E., del Marmol, Veronique, Marzano, Angelo V., Prens, Errol P., Tzellos, Thrasyvoulos, Zouboulis, Christos C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2021
Onderwerpen:
10th European Hidradenitis Suppurativa (EHSF) e.V. Conference
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207032/
https://ncbi.nlm.nih.gov/pubmed/34085330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/exd.14339
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items